Exposure and contamination assessment of nuclear medical staff during radioiodine therapy for thyroid cancer

被引:1
作者
Guillot, S. [1 ]
Tylski, P. [1 ]
Scheiber, C. [2 ]
Bournaud-Salinas, C. [2 ]
Bolot, C. [3 ]
Harthe, C. [4 ]
Jalade, P. [1 ]
机构
[1] Hosp Civils Lyon, Serv Phys Med & Radioprotect, Groupement Hosp Sud, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France
[2] Hosp Civils Lyon, Groupement Hosp Est, Ctr Med Nucl, 59 Blvd Pinel, F-69677 Bron, France
[3] Hosp Civils Lyon, Groupement Hosp Est, Radiopharm, 59 Blvd Pinel, F-69677 Bron, France
[4] Hosp Civils Lyon, Groupement Hosp Est, Ctr Biol Est, 59 Blvd Pinel, F-69677 Bron, France
关键词
Iodine-131; contamination; thyroid; therapy;
D O I
10.1051/radiopro/2016030
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
To assess exposure and contamination induced by patients treated with iodine-131 on nuclear medical staff, we performed several measurements during patient hospitalization: the dose rate, skin contamination, and room air and ground contamination. These measurements were performed for 12 patients treated with 3.7 GBq of iodine131, 6 stimulated by TSHr and 6 by thyroid hormone withdrawal. Maximum values were measured 4 h after iodine administration, with a mean dose rate of 133 mu Sv h(-1) at 1 meter, a mean activity concentration of 8.8 MBq g(-1) in saliva, a mean room air concentration of 183 Bq m(-3) and a ground concentration below 0.5 Bq cm(-2). These results highlight a wide inter-patient variability, resulting from individual physiological differences in iodine elimination and from various applications of hygiene instructions. Room air contamination has a small impact in terms of staff exposure, compared with external exposure from the patient. Nevertheless, it is probably the main origin of internal contamination of nuclear medical staff. It is now recommended for the staff to limit visits in the room in the first 24 h, and for all patients to strictly follow hygiene instructions.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 8 条
[1]  
Be M.M., 2008, CEAR6201
[2]  
CEA/LNHB-SFPM-SoFRa, 2006, GUID UT CONTR QUAL A
[3]  
Delacroix D, 2004, GUIDE PRATIQUE RADIO
[4]  
IBIS E, 1992, J NUCL MED, V33, P2110
[5]  
ICRP Publication 68, 1994, ANN ICRP, V24
[6]  
INRS FR8, 2012, FR8 INRS, P143
[7]  
Nmz H, 2012, JDMS, V2, P27
[8]   131I effective half-life and dosimetry in thyroid cancer patients [J].
Remy, Herve ;
Borget, Isabelle ;
Lebulieux, Sophie ;
Guilabert, Nadine ;
Lavielle, Frederic ;
Garsi, Jerome ;
Bournaud, Claire ;
Gupta, Severine ;
Schlumberger, Martin ;
Ricard, Marcel .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) :1445-1450